Huawei Joins UNESCO Global Alliance for Literacy to Step Up Talent Cultivation
28.2.2023 13:47:00 EET | Business Wire | Press release
Huawei announced it has joined the UNESCO Global Alliance for Literacy (GAL) on February 26th as part of the company’s lead up to the Mobile World Congress 2023. The announcement was made at a Digital Talent Summit co-hosted by Huawei and the UNECSO Institute for Lifelong Learning (UIL) which serves as the Secretariat of the GAL.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230228005765/en/
Representative from Huawei and UNESCO Institute for Lifelong Learning signs agreement (Photo: Huawei)
At the Summit, Huawei and the UIL agreed to jointly promote the use of technology to raise literacy. The two parties also signed a cooperation agreement under which Huawei will fund an expansion of the UIL’s current initiatives to enhance educators’ use of technology in developing countries. Currently, the UIL initiative operates in Bangladesh, Côte d’Ivoire, Egypt, Nigeria, and Pakistan.
Huawei is the first private company to become an associate member of the GAL and the company is excited its own goals align with the GAL’s vision of eradicating digital illiteracy in young people.
UIL Director David Atchoarena explained at the event, “Our rapidly changing world calls for concerted efforts and strong partnerships to achieve quality education and lifelong learning for all.”
Atchoarena continued, “Huawei’s expertise in the area of innovation in learning will be a great asset to the Global Alliance for Literacy. Collaborative projects such as ours will ensure that no one is left behind on this journey.”
Huawei’s own Vice President of Corporate Communications Vicky Zhang also commented, “Getting the right education is often the key to success in life. As a major player in the technology sector, Huawei feels it has a responsibility to provide technology skills in all parts of the world, trying our best to include as many people as possible.”
“We are proud to join forces with UNESCO to better deliver on this responsibility,” Zhang added.
Huawei believes digital talent is a key driver in achieving digital transformation, solid economic growth, and better quality of life. Since 2008, Huawei has offered a wide and expanding range of talent programs. Under its Seeds for the Future umbrella, Huawei provides tens of thousands of people every year with scholarships and digital training courses targeting all age groups. The company also organizes and sponsors tech competitions where students can expand their knowledge, win prizes, and make new friends.
Dr. Piti Srisangnam, Executive Director of ASEAN Foundation applauded Huawei’s contribution to the local talent community. “The ASEAN Seeds for the Future program that we launched in 2022 together with Huawei has already become a resourceful platform for hundreds of local students in ten ASEAN countries to learn ICT knowledge and have cultural exchanges,” he said.
John Omo, Secretary General of African Telecommunication Union (ATU), also emphasized on the necessity of bridging the local talent to the international community. He said, “It is critical that youth in Africa have access to global opportunities and can be a part of global conversations.”
Sen. Jorge Ramirez Marin, President of the Commission of Science and Technology of Mexico Senate also called for a global synergy. “Digital education should be a factor that brings us closer to equity, instead of aggravating inequality,” he said.
The summit concluded with a profound and interesting panel session on imagining the future of education. The panel discussion was shared by George Gilder, the renowned economist and co-founder of the Discovery Institute, Dr. Ricardo Gil-da-Costa, the CEO and co-founder of Neuroverse, and two Huawei Seeds for the Future alumni.
So far, Huawei’s Seeds for the Future program has helped nurture more than 2.2 million digital talents in over 150 countries. The company’s ICT Academy can train about 200,000 students each year. In 2021, Huawei announced it had already invested US$150 million and planned invest another US$150 million in digital talent development before 2026, which is expected to benefit an additional 3 million people.
About the Global Alliance for Literacy
Since its launch in 2016, the Global Alliance for Literacy has driven international discourse and guided the agenda for literacy provision globally for those who need it most. The alliance includes 30 countries committed to improving youth and adult literacy. It serves as a platform for its members to discuss progress and challenges together, and to exchange knowledge and good practice.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230228005765/en/
Contact information
Colin Qian
qianzhecheng@huawei.com
+86 18036392250
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release
Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
